Trending News

Curaleaf: Analysts Are Hopeful ahead of Q3 Release

Curaleaf is set to report its third-quarter earnings results on November 19. It's fallen more than 6% since it announced its earnings date.

Cannabis Sector: The Worst Isn’t Over

The cannabis sector is running high on negative sentiment after two of its biggest players reported disappointing earnings on November 14.

Why Cronos’s Listing in Australia Is Important

Cronos Australia (CAU.AX) was recently listed on the Australian Stock Exchange. Its IPO recently raised 20 million Australian dollars.

Aurora Cannabis’s Earnings Coming after Hours

Aurora Cannabis (ACB)(ACB.TO) plans to announce its earnings after the market closes. However, its stock is already trading on a weak note.

Canopy Growth: An Overview of the Cannabis Giant

Canopy Growth operates in 14 countries on five continents. The company has expanded through strategic partnerships, acquisitions, and supply agreements.

Acreage’s Q3 Missed Expectations, but It’s Optimistic

Acreage Holdings reported its third-quarter earnings results on November 12. The company's earnings were lower than analysts' expectations.

Tilray Tumbles following Its Q3 Earnings Report

Tilray reported its third-quarter earnings results on November 12. It reported five times its revenue from last year's third quarter.

Aleafia Health Hits a Profit Milestone in Q3

Aleafia Health reported its third-quarter earnings results on November 12. The cannabis producer reported a positive net profit for the first time.

Cannabis Players are Looking at Consumer Goods

Cannabis companies are having problems in earning profits quickly. It's becoming clear that the industry is facing challenges from illegal market products.

GW Pharmaceuticals: Analysts’ Ratings, Price Target

GW Pharmaceuticals (GWPH) recently reported its QA3 results. Although its financials beat estimates, the company's stock has fallen 18% since then.

Canopy Growth Sponsors Clinical Trial of CBD

According to recent news, Canopy Growth is sponsoring a clinical trial exploring CBD's effects on social anxiety disorder.

Canopy Growth under Investigation for Fraud

Law firm Ademi & O'Reilly is currently investigating fraud claims against the global cannabis producer Canopy Growth (CGC) (WEED).

Featured

Most popular life news you must read today

Canopy Growth under Investigation for Fraud

Law firm Ademi & O'Reilly is currently investigating fraud claims against the global cannabis producer Canopy Growth (CGC) (WEED).

Cannabis Sector: The Worst Isn’t Over

The cannabis sector is running high on negative sentiment after two of its biggest players reported disappointing earnings on November 14.

Charlotte’s Web to Develop Cannabis Spirits?

Charlotte's Web Holdings recently appointed Jacques Tortoroli to its board of directors. He previously served as Bacardi's chief administrative officer.

Popular

Canopy Growth under Investigation for Fraud

Law firm Ademi & O'Reilly is currently investigating fraud claims against the global cannabis producer Canopy Growth (CGC) (WEED).

OrganiGram’s Q4: Big 2019 Growth, Big 2020 Plans?

OrganiGram is set to report its fiscal 2019 fourth-quarter earnings results on November 25. It will report its numbers for the quarter and the full year.

Cannabis Sector: The Worst Isn’t Over

The cannabis sector is running high on negative sentiment after two of its biggest players reported disappointing earnings on November 14.

Organigram Optimistic about Ontario’s Legal Cannabis

Organigram Holdings Inc. (OGI) offered its support to the new click-and-collect system in Ontario's retail cannabis system.

Why Cronos’s Listing in Australia Is Important

Cronos Australia (CAU.AX) was recently listed on the Australian Stock Exchange. Its IPO recently raised 20 million Australian dollars.

Cannabis Sector: Five Reasons Investors Are on Edge

Four cannabis companies are set to release their earnings results this week, and investors seem worried. Let's take a look at why.

Canopy Growth under Investigation for Fraud

Law firm Ademi & O'Reilly is currently investigating fraud claims against the global cannabis producer Canopy Growth (CGC) (WEED).

Cannabis Players are Looking at Consumer Goods

Cannabis companies are having problems in earning profits quickly. It's becoming clear that the industry is facing challenges from illegal market products.

Portfolio Tracker

Andrew Yang Launches Marijuana Merchandise for 2020

Read More Andrew Yang, a 2020 presidential candidate, launched...

Cannabis Legalization: New Jersey Continues to Wait

On September 12, the New Jersey Senate was set...

Vaping Warning by CDC Should Worry Cannabis Players

On August 23, Illinois’s Department of Public Health reported...

President Trump: Is Marijuana Legalization a Key Weapon?

President Trump hasn’t shared his views on marijuana yet....

Marijuana Legalization: Is the White House Warming Up?

Read More Marijuana Legalization: Is the White House Warming Up? Marijuana...

Can Elizabeth Warren’s Stance on Cannabis Win Voters?

Cannabis legalization has emerged as one of the key...

Supreme Cannabis: Analysts’ Target Price and Ratings

Supreme Cannabis (FIRE) reported its fourth-quarter earnings on September...